Cargando…
Cancer immunotherapy: Moving beyond checkpoint inhibition
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290967/ https://www.ncbi.nlm.nih.gov/pubmed/30564293 http://dx.doi.org/10.18632/oncotarget.26384 |
_version_ | 1783380180202422272 |
---|---|
author | Boes, Marianne |
author_facet | Boes, Marianne |
author_sort | Boes, Marianne |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6290967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62909672018-12-18 Cancer immunotherapy: Moving beyond checkpoint inhibition Boes, Marianne Oncotarget Editorial Impact Journals LLC 2018-11-27 /pmc/articles/PMC6290967/ /pubmed/30564293 http://dx.doi.org/10.18632/oncotarget.26384 Text en Copyright: © 2018 Boes. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Editorial Boes, Marianne Cancer immunotherapy: Moving beyond checkpoint inhibition |
title | Cancer immunotherapy: Moving beyond checkpoint inhibition |
title_full | Cancer immunotherapy: Moving beyond checkpoint inhibition |
title_fullStr | Cancer immunotherapy: Moving beyond checkpoint inhibition |
title_full_unstemmed | Cancer immunotherapy: Moving beyond checkpoint inhibition |
title_short | Cancer immunotherapy: Moving beyond checkpoint inhibition |
title_sort | cancer immunotherapy: moving beyond checkpoint inhibition |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290967/ https://www.ncbi.nlm.nih.gov/pubmed/30564293 http://dx.doi.org/10.18632/oncotarget.26384 |
work_keys_str_mv | AT boesmarianne cancerimmunotherapymovingbeyondcheckpointinhibition |